Titan Pharmaceuticals, Inc. Increase (Decrease) in Notes Receivables
Titan Pharmaceuticals, Inc. reported Increase (Decrease) in Notes Receivables of -$1.00 million for the 9-month period ending 2024-09-30, per its 10-Q filed 2025-01-03.
Financial Statements › Cash Flow › Operating Activities
us-gaap:IncreaseDecreaseInNotesReceivables · last filed 2025-08-14
- Titan Pharmaceuticals, Inc. increase (decrease) in notes receivables for the quarter ending 2024-09-30 was $0.00.
- Titan Pharmaceuticals, Inc. increase (decrease) in notes receivables for the quarter ending 2024-06-30 was $0.00.
- Titan Pharmaceuticals, Inc. increase (decrease) in notes receivables for the quarter ending 2024-03-31 was -$1.00M.
| Period end | Increase (Decrease) in Notes Receivables 3 month | Increase (Decrease) in Notes Receivables 6 month | Increase (Decrease) in Notes Receivables 9 month |
|---|---|---|---|
| 2024-09-30 | $0.00 derived: 10-Q 9 month − 10-Q 6 month · filed 2025-01-03 | $0.00 derived: sum of 2 quarters · filed 2025-08-14 | -$1.00M 10-Q · filed 2025-01-03 |
| 2024-06-30 | $0.00 derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-14 | -$1.00M 10-Q · filed 2025-08-14 | |
| 2024-03-31 | -$1.00M 10-Q · filed 2025-05-14 |